BR112020019875A8 - composições tópicas para alívio da dor - Google Patents
composições tópicas para alívio da dorInfo
- Publication number
- BR112020019875A8 BR112020019875A8 BR112020019875A BR112020019875A BR112020019875A8 BR 112020019875 A8 BR112020019875 A8 BR 112020019875A8 BR 112020019875 A BR112020019875 A BR 112020019875A BR 112020019875 A BR112020019875 A BR 112020019875A BR 112020019875 A8 BR112020019875 A8 BR 112020019875A8
- Authority
- BR
- Brazil
- Prior art keywords
- pain relief
- topical compositions
- cannabinoid
- magnesium salt
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000000699 topical effect Effects 0.000 title abstract 3
- 229930003827 cannabinoid Natural products 0.000 abstract 2
- 239000003557 cannabinoid Substances 0.000 abstract 2
- 159000000003 magnesium salts Chemical class 0.000 abstract 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 abstract 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 229960001047 methyl salicylate Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
a presente invenção descreve composições para uso tópico compreendendo agentes ativos para fornecer alívio da dor. as composições compreendem um sal de magnésio, um canabinoide e pelo menos um agente analgésico tópico adicional. adicionalmente descritos neste documento são métodos para tratar a dor compreendendo administrar a uma pessoa com necessidade do mesmo uma composição compreendendo uma quantidade farmaceuticamente eficaz de um canabinoide, um sal de magnésio e pelo menos um de: salicilato de metila e mentol.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862696341P | 2018-07-11 | 2018-07-11 | |
US62/696,341 | 2018-07-11 | ||
PCT/IL2019/050776 WO2020012480A1 (en) | 2018-07-11 | 2019-07-11 | Pain-relieving topical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112020019875A2 BR112020019875A2 (pt) | 2021-01-05 |
BR112020019875A8 true BR112020019875A8 (pt) | 2021-03-30 |
Family
ID=69141685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112020019875A BR112020019875A8 (pt) | 2018-07-11 | 2019-07-11 | composições tópicas para alívio da dor |
Country Status (10)
Country | Link |
---|---|
US (1) | US11696909B2 (pt) |
EP (1) | EP3735225A4 (pt) |
BR (1) | BR112020019875A8 (pt) |
CA (1) | CA3092289A1 (pt) |
CO (1) | CO2021000174A2 (pt) |
IL (1) | IL276443A (pt) |
MX (1) | MX2021000376A (pt) |
RU (1) | RU2754846C1 (pt) |
UA (1) | UA124181C2 (pt) |
WO (1) | WO2020012480A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210113490A1 (en) * | 2019-10-21 | 2021-04-22 | Avicanna Inc. | Topical cannabinoid compositions for clear skin |
US11850217B2 (en) | 2020-05-20 | 2023-12-26 | Advanced Food Concepts, Inc. | Athletic performance enhancement composition using menthol |
CA3185514A1 (en) * | 2020-07-17 | 2022-01-20 | Ramachandra MUKUNDA | Cannabidiol (cbd) based composition and method for treating pain |
US20220054446A1 (en) * | 2020-08-18 | 2022-02-24 | Yvette Rose Webb | Targeted treatment with a topical cream of cannabinoids, terpenes, and essential oils |
US11478446B2 (en) | 2020-08-28 | 2022-10-25 | Teresa Ann HANLON | Pain relieving formulations containing cannabis and methods of making same |
WO2022189945A1 (en) * | 2021-03-08 | 2022-09-15 | Avicanna Inc. | Topical cannabinoid compositions and methods for treating skin diseases |
WO2022190082A1 (en) * | 2021-03-09 | 2022-09-15 | Innocan Pharma Ltd. | Biphasic compositions for treatment of indications of the skin |
CN113318071A (zh) * | 2021-06-17 | 2021-08-31 | 广州泰柯碧缇科技有限公司 | 一种治疗足部、膝盖病痛的凝胶及其制备方法 |
US20230310297A1 (en) | 2022-04-01 | 2023-10-05 | TF Holdings LLC | Skin treatment composition containing cannabinoids |
US20240041901A1 (en) | 2022-08-02 | 2024-02-08 | TF Holdings LLC | Wound treatment topical composition containing cannabinoids |
US11826342B1 (en) | 2022-09-27 | 2023-11-28 | Saaransh Mahna | Cannabidiol formulation for alleviating pain and a method of manufacturing |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
EP2424568A1 (en) * | 2009-04-29 | 2012-03-07 | University Of Kentucky Research Foundation | Cannabinoid-containing compositions and methods for their use |
US9717757B1 (en) | 2011-12-28 | 2017-08-01 | Samuel N. Gasque, Jr. | Composition and method to treat and prevent muscle cramping |
US20140018750A1 (en) | 2012-07-10 | 2014-01-16 | Michael J. Pagliaro | Method and device or pharmaceutical compositions for the transdermal delivery of magnesium directly to the neuromuscular junction for the treatment of muscle cramping |
US9375417B2 (en) * | 2014-12-04 | 2016-06-28 | Mary's Medicinals LLC | Transdermal cannabinoid formulations |
-
2019
- 2019-07-11 EP EP19834499.6A patent/EP3735225A4/en active Pending
- 2019-07-11 MX MX2021000376A patent/MX2021000376A/es unknown
- 2019-07-11 WO PCT/IL2019/050776 patent/WO2020012480A1/en unknown
- 2019-07-11 RU RU2020129301A patent/RU2754846C1/ru active
- 2019-07-11 US US16/968,627 patent/US11696909B2/en active Active
- 2019-07-11 CA CA3092289A patent/CA3092289A1/en active Pending
- 2019-07-11 UA UAA202006591A patent/UA124181C2/uk unknown
- 2019-07-11 BR BR112020019875A patent/BR112020019875A8/pt unknown
-
2020
- 2020-08-02 IL IL276443A patent/IL276443A/en unknown
-
2021
- 2021-01-13 CO CONC2021/0000174A patent/CO2021000174A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
CO2021000174A2 (es) | 2021-01-18 |
UA124181C2 (uk) | 2021-07-28 |
EP3735225A1 (en) | 2020-11-11 |
IL276443A (en) | 2020-09-30 |
BR112020019875A2 (pt) | 2021-01-05 |
RU2754846C1 (ru) | 2021-09-08 |
EP3735225A4 (en) | 2020-11-11 |
US11696909B2 (en) | 2023-07-11 |
US20210046040A1 (en) | 2021-02-18 |
CA3092289A1 (en) | 2020-01-16 |
WO2020012480A1 (en) | 2020-01-16 |
MX2021000376A (es) | 2021-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112020019875A8 (pt) | composições tópicas para alívio da dor | |
CL2017002939A1 (es) | Composiciones farmacéuticas tópicas | |
MX2021006421A (es) | Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17). | |
BR112015023922A2 (pt) | composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes | |
BR112015021371A2 (pt) | uso de agonistas de receptor de formil peptídeo 2 para tratar doenças inflamatórias oculares | |
CO7101246A2 (es) | Compuesto de carbamato y preparación y uso de los mismos | |
BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
CL2008001268A1 (es) | Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor. | |
BR112014004741A2 (pt) | pelo menos uma entidade química; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada | |
AR096892A1 (es) | Una combinación farmacéutica para el tratamiento del melanoma | |
BR112016027043A8 (pt) | combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer | |
MX2009011900A (es) | Curacion de herida diabetica. | |
AR101901A1 (es) | Tratamiento de enfermedades neurodegenerativas con una combinación de laquinimod y fingolimod | |
BR112019005578A2 (pt) | compostos de indazol para uso em lesões no tendão e/ou ligamento | |
BR112015022084A2 (pt) | composições para uso em tratamento de distúrbios oculares com o uso de dipiridamol | |
BR112015012497A2 (pt) | combinações farmacêuticas | |
BR112015019524A2 (pt) | tratamento de combinação | |
BR112019022459A2 (pt) | Agente terapêutico para câncer no sangue | |
CL2015002188A1 (es) | Agentes analgésicos oculares tópicos | |
BR112015031835A8 (pt) | agentes terapêuticos, combinação dos referidos agentes e agente terapêutico adicional, uso dos referidos agentes e da referida combinação para fabricação de medicamento para a profilaxia e/ou tratamento de distúrbios do movimento hipercinético | |
CL2016002655A1 (es) | Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol | |
BR112021025291A2 (pt) | Dispositivos de contenção de medicamento e composições associadas | |
BR112016012141A2 (pt) | "combinações farmacêuticas, uso das mesmas, e embalagem comercial" | |
MX2023006235A (es) | Composiciones para administracion de farmacos y metodos de uso de las mismas. | |
AR122320A1 (es) | Composiciones tópicas para el alivio del dolor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |